Barclays Maintains an 'Equalweight' on Ingram Micro (IM); Pre-announces Weaker-than-Expected 3Q11 Earnings as Issues Linger
Get Alerts IM Hot Sheet
Price: $38.89 --0%
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Ingram Micro (NYSE: IM) price target cut $1 to $18.
Barclays analyst says, "We are lowering our EPS estimates for IM based on our view that margins and revenues will continue to be under pressure in EMEA and in APAC into next year. For F3Q11, we now estimate EPS of $0.33 (was $0.40) based on 5.3% y/y revenue growth to $8.89bn (was $8.90bn). For F4Q11, we now estimate EPS of $0.57 (was $0.69) and revenue of $10.2bn (was $10.3bn). For FY11 we now estimate EPS of $1.61 (was $1.80) and revenue of $36.6bn (was $36.7bn). For FY12 we now estimate EPS of $1.93 (was $2.15) and revenue of $37.9bn (was $38.4bn)."
For more ratings news on Ingram Micro click here and for the rating history of Ingram Micro click here.
Shares of Ingram Micro closed at $18.72 yesterday.
Barclays analyst says, "We are lowering our EPS estimates for IM based on our view that margins and revenues will continue to be under pressure in EMEA and in APAC into next year. For F3Q11, we now estimate EPS of $0.33 (was $0.40) based on 5.3% y/y revenue growth to $8.89bn (was $8.90bn). For F4Q11, we now estimate EPS of $0.57 (was $0.69) and revenue of $10.2bn (was $10.3bn). For FY11 we now estimate EPS of $1.61 (was $1.80) and revenue of $36.6bn (was $36.7bn). For FY12 we now estimate EPS of $1.93 (was $2.15) and revenue of $37.9bn (was $38.4bn)."
For more ratings news on Ingram Micro click here and for the rating history of Ingram Micro click here.
Shares of Ingram Micro closed at $18.72 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
- Zurn Water Solutions (ZWS) Reiterated at Buy by Stifel on New Product Development Momentum
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Barclays, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share